<DOC>
	<DOCNO>NCT01142024</DOCNO>
	<brief_summary>With wide use contrast agent clinical diagnosis treatment , contrast induce nephropathy ( CIN ) account 1/3 hospital acquire acute renal failure.The mortality rate patient CIN 35 % , 30 % patient permanent renal dysfunction.Prevention treatment iatrogenic complication reduce morbidity become urgent task every medical worker . Now pathogenesis CIN clear , toxicity renal tubular epithelial cell hypoxia renal medullary likely main mechanism CIN.Iodine contrast agent concentrate tubular collect duct directly damage cell , lead tubular cell death ; also induce release renal vasoconstrictor , adenosine , endothelin , cause acute vasoconstriction.Furthermore , oxidative stress inflammatory response induce ischemia may worsen kidney function . Thus large number study focus oxidative stress pathogenesis CIN.Recently , study show oxidative stress protein play important role acute renal injury ( AKI ) , report protein different genotype relate incidence prognosis AKI . Therefore , investigator speculate whether patient genetic potential increase oxidative stress , prone contrast induce nephropathy ? At present , great number research preventive measure CIN.The firstly widely use therapy hydration.But dilute iodine contrast medium renal tubular collect duct , increase urine output prevent formation tubular crystals.According pathogenesis CIN , oxidative stress play important role CIN , thereby several antioxidant , N-acetyl cysteine Glutathione also study.But result inconsistent . As result , investigator design study evaluate oxidative stress cardiovascular population impact contrast medium nephropathy , relationship antioxidant enzymes genetic polymorphism , find clinical indicator predict renal dysfunction guide individual treatment prevent occurrence .</brief_summary>
	<brief_title>Polymorphism Oxidative Stress Genes Pathogenesis Antioxidant Prevention Contrast Induced Nephropathy</brief_title>
	<detailed_description>With wide use contrast agent clinical diagnosis treatment , contrast induce nephropathy ( CIN ) account 1/3 hospital acquire acute renal failure , lead prolonged hospital stay increase medical costs.The mortality rate patient CIN 35 % , 30 % patient permanent renal dysfunction.Prevention treatment iatrogenic complication reduce morbidity become urgent task every medical worker . Now pathogenesis CIN clear , toxicity renal tubular epithelial cell hypoxia renal medullary likely main mechanism CIN.Iodine contrast agent concentrate tubular collect duct directly damage cell , lead tubular cell death ; also induce release renal vasoconstrictor , adenosine , endothelin , cause acute vasoconstriction.Furthermore , oxidative stress inflammatory response induce ischemia may worsen kidney function . Thus large number study focus oxidative stress pathogenesis CIN.Recently , study show oxidative stress protein , NADPH oxidase p22 phox subunit , promote oxidase , antioxidant enzyme catalase , hypoxia inducible factor-1 ( HIF-1 ) , play important role acute renal injury ( AKI ) , report protein different genotype relate incidence prognosis AKI , NADPH oxidase subunit p22 phox ( position point +242 T replace C ) . Therefore , investigator speculate whether patient genetic potential increase oxidative stress , prone contrast induce nephropathy ? At present , great number research preventive measure CIN.The firstly widely use therapy hydration.But dilute iodine contrast medium renal tubular collect duct , increase urine output prevent formation tubular crystals.According pathogenesis CIN , oxidative stress play important role CIN , thereby several antioxidant , N-acetyl cysteine ( NAC ) Glutathione also study.But result inconsistent . As result , investigator design prospective , randomize , control study evaluate oxidative stress cardiovascular population impact contrast medium nephropathy , relationship antioxidant enzymes genetic polymorphism , find clinical indicator predict renal dysfunction guide individual treatment prevent occurrence . Inclusion Criteria : - receive cardiovascular angiography ; age 18 80 year ; sign informed consent . Exclusion Criteria : - serum creatinine level great 8 mg / dL ( 707 μmol / L ) ; change serum creatinine 0.5 mg / dL ( 44.2 μmol / L ) 24 hour randomization ; dialysis , multiple myeloma , pulmonary edema , uncontrolled hypertension , emergency cardiac catheterization , exposure radiographic contrast medium within precede 2 day , allergy radiographic contrast medium , pregnancy breast-feeding woman , acceptance mannitol anti-oxidant treatment .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>receive cardiovascular angiography ; age 18 80 year ; sign informed consent . baseline serum creatinine level &gt; 8 mg / dL ( 707 μmol / L ) ; increase serum creatinine 0.5 mg / dL ( 44.2 μmol / L ) 24 hour angiography ; dialysis ; multiple myeloma ; pulmonary edema ; uncontrolled hypertension ; emergency cardiac catheterization ; exposure radiographic contrast medium within precede 2 day ; allergy radiographic contrast medium ; pregnancy breastfeed woman ; acceptance mannitol antioxidant treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>contrast medium induce nephropathy</keyword>
	<keyword>polymorphism oxidative stress gene</keyword>
	<keyword>antioxidant prevention</keyword>
</DOC>